Innovotech Inc. (CVE:IOT – Get Free Report) traded down 41% during trading on Wednesday . The company traded as low as C$0.11 and last traded at C$0.12. 591,310 shares were traded during trading, an increase of 1,389% from the average session volume of 39,725 shares. The stock had previously closed at C$0.20.
Innovotech Price Performance
The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The business’s 50-day simple moving average is C$0.20 and its 200 day simple moving average is C$0.23. The firm has a market capitalization of C$7.08 million, a P/E ratio of 70.46 and a beta of 2.86.
Innovotech Company Profile
Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.
Read More
- Five stocks we like better than Innovotech
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.
